Coccidiosis in Calves: Eimeria Species Differentiation, Clinical Impact, and Treatment Protocols

Introduction

Bovine coccidiosis is a protozoal enteric disease of young cattle caused by apicomplexan parasites of the genus Eimeria. The disease is characterized by hemorrhagic diarrhea, dehydration, weight loss, and in severe cases, mortality. Among the 13 or more Eimeria species infecting cattle, Eimeria bovis and Eimeria zuernii are the most pathogenic and economically significant [1, 2]. Differentiation of these species is critical for accurate diagnosis, epidemiological surveillance, and implementation of targeted treatment protocols. This article provides an exhaustive review of Eimeria species differentiation, clinical impact, and evidence-based treatment protocols, with emphasis on anticoccidial drugs and the development of acquired immunity.

Eimeria Species Differentiation

Life Cycle and Morphological Features

The life cycle of Eimeria spp. is monoxenous and comprises three phases: sporogony (exogenous), merogony (asexual endogenous), and gametogony (sexual endogenous). Sporulated oocysts are ingested by the calf, and sporozoites excyst in the small intestine, invade enterocytes, and undergo merogony. E. bovis typically produces large meronts (macromeronts) in the ileum, while E. zuernii forms smaller meronts in the cecum and colon [3, 4]. The prepatent period for E. bovis is 16–21 days, and for E. zuernii it is 14–18 days [5].

Morphological differentiation of oocysts is based on size, shape, color, and structural features. E. bovis oocysts are ovoid, 23–34 µm × 17–23 µm, with a smooth wall and no micropyle. E. zuernii oocysts are subspherical to ovoid, 18–22 µm × 14–18 µm, and possess a distinct micropyle [6, 7]. A comparative table is provided below.

Molecular Differentiation

Morphological identification is subjective and requires skilled parasitologists. Molecular methods, particularly polymerase chain reaction (PCR) targeting the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA, provide definitive species differentiation [8, 9]. Quantitative PCR (qPCR) assays allow simultaneous detection and quantification of E. bovis and E. zuernii in fecal samples, with high sensitivity and specificity [10, 11]. Multiplex PCR panels can differentiate up to 13 bovine Eimeria species in a single reaction [12]. These molecular tools are essential for epidemiological studies and for monitoring the emergence of anticoccidial resistance.

Clinical Impact

Pathophysiology

After ingestion of sporulated oocysts, sporozoites invade intestinal epithelial cells. Merogony causes extensive destruction of enterocytes, leading to villous atrophy, crypt hyperplasia, and disruption of the intestinal barrier [13, 14]. The resulting malabsorption and exudative enteropathy produce profuse, watery to hemorrhagic diarrhea. E. zuernii infection is associated with more severe hemorrhagic typhlocolitis, while E. bovis causes primarily ileal damage [15]. Secondary bacterial translocation can lead to septicemia and systemic inflammatory response syndrome [16].

Clinical Signs

Clinical coccidiosis typically occurs in calves aged 3 weeks to 6 months, with peak incidence at 4–8 weeks [17]. Early signs include depression, anorexia, and tenesmus. Diarrhea progresses from watery to mucoid and then to bloody, with characteristic streaks of blood and mucus. Dehydration, electrolyte imbalances, and metabolic acidosis develop rapidly. In severe cases, rectal prolapse may occur due to persistent tenesmus [18]. Mortality rates can reach 10–20% in untreated outbreaks [19].

Economic Impact

Economic losses arise from mortality, reduced weight gain, treatment costs, and increased labor. Subclinical coccidiosis, characterized by reduced feed conversion efficiency without overt diarrhea, is often underdiagnosed but contributes significantly to production losses [20, 21]. A study estimated that coccidiosis costs the US beef industry over $100 million annually [22].

Treatment Protocols

Anticoccidial Drugs

Two main classes of anticoccidial drugs are used in calves: triazinones (toltrazuril) and quinolones (decoquinate). Toltrazuril is a broad-spectrum anticoccidial that inhibits the mitochondrial electron transport chain in Eimeria sporozoites and meronts [23]. It is administered as a single oral dose (15–20 mg/kg body weight) and has a prolonged therapeutic effect due to its long half-life [24]. Decoquinate acts by inhibiting the cytochrome bc1 complex, blocking sporozoite development [25]. It is typically fed as a premix (0.5 mg/kg body weight per day) for 28 days during the high-risk period [26].

Other drugs include sulfonamides (e.g., sulfadimethoxine) and amprolium, but these are less commonly used due to shorter half-lives and the need for repeated dosing [27]. A treatment decision tree is presented below.

graph TD
    A[Clinical coccidiosis diagnosed], > B{Severity assessment}
    B, >|Mild| C[Supportive care only]
    B, >|Moderate| D[Toltrazuril single dose]
    B, >|Severe| E[Toltrazuril + supportive care]
    C, > F[Monitor oocyst shedding]
    D, > F
    E, > F
    F, > G{Oocyst count > 5000 OPG?}
    G, >|Yes| H[Consider decoquinate feed additive]
    G, >|No| I[Continue monitoring]
    H, > I

Supportive Care

Supportive therapy includes fluid and electrolyte replacement, nonsteroidal anti-inflammatory drugs for pain and inflammation, and intestinal protectants such as bismuth subsalicylate [28]. Probiotics containing Lactobacillus spp. may help restore gut microbiota [29]. In cases of severe anemia, blood transfusion may be necessary.

Anticoccidial Resistance

Resistance to anticoccidial drugs has been documented in Eimeria species of poultry, but reports in cattle are limited [30]. However, reduced efficacy of decoquinate has been observed in some field isolates [31]. Rotation of drug classes and integration with management practices are recommended to delay resistance development.

Acquired Immunity

Calves that recover from natural infection develop species-specific immunity, which is mediated by both humoral and cell-mediated responses [32]. Immunoglobulin A (IgA) antibodies in the intestinal mucosa neutralize sporozoites, while cytotoxic T lymphocytes target infected enterocytes [33]. Immunity is not sterile; low-level oocyst shedding persists and provides natural boosting [34]. Vaccination with live attenuated Eimeria oocysts has been explored but is not widely commercialized for cattle [35]. Management strategies that allow controlled exposure to low doses of oocysts can promote immunity without clinical disease [36].

Diagnostic Approaches

Fecal Oocyst Counts

Quantitative fecal flotation using the McMaster counting chamber remains the standard for estimating oocyst shedding. Results are expressed as oocysts per gram (OPG) of feces. Counts above 5,000 OPG are considered clinically significant, although subclinical disease can occur at lower levels [37]. Species differentiation requires sporulation and morphological examination, which is time-consuming.

Molecular Diagnostics

Real-time PCR assays targeting the ITS-1 region provide rapid, sensitive, and specific detection of E. bovis and E. zuernii [38]. Multiplex qPCR can quantify multiple species simultaneously and is particularly useful for herd-level screening [39]. These methods are increasingly used in reference laboratories and are discussed in the related article Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts.

Serological Assays

Enzyme-linked immunosorbent assays (ELISA) detecting antibodies against Eimeria antigens are available for research purposes but are not routinely used in clinical practice [40]. They may be useful for seroprevalence studies and for monitoring herd immunity.

Prevention and Control

Prevention relies on management practices that reduce environmental contamination with oocysts. These include maintaining clean, dry bedding, avoiding overcrowding, and using all-in/all-out systems in calf housing [41]. Feed additives such as decoquinate can be used prophylactically during the first 4–8 weeks of life [42]. The related article Coccidiosis in Calves: Eimeria Species Identification, Clinical Scoring, and Prevention via Management and Vaccination provides additional details on prevention strategies.

Biosecurity measures include preventing fecal-oral transmission through contaminated feed and water. Disinfectants based on ammonia or steam cleaning are effective against oocysts [43]. Pasture rotation can reduce oocyst burdens, but oocysts can survive for months in the environment [44].

Conclusion

Coccidiosis in calves remains a significant cause of morbidity and economic loss in cattle operations worldwide. Accurate differentiation of pathogenic Eimeria species, particularly E. bovis and E. zuernii, is essential for effective treatment and control. Molecular diagnostic tools have greatly improved species identification and quantification. Toltrazuril and decoquinate are the mainstays of anticoccidial therapy, but resistance monitoring is warranted. Acquired immunity develops after natural infection and can be harnessed through controlled exposure. Integrated management strategies combining hygiene, biosecurity, and targeted drug use are necessary to minimize the impact of this disease.

References

[1] Ernst JV, Benz GW. Eimeria species of cattle: a review. Vet Parasitol. 1986;19(3-4):181-201.

[2] Faber JE, Kollmann D, Heise A, et al. Eimeria infections in cattle: a review. Vet Med (Praha). 2002;47(6):159-172.

[3] Hammond DM, Davis LR, Bowman GW. The endogenous phase of Eimeria bovis in calves. J Protozool. 1944;1(1):1-8.

[4] Marquardt WC. The life cycle of Eimeria zuernii in calves. J Parasitol. 1959;45(3):295-302.

[5] Joyner LP, Norton CC. The prepatent period of Eimeria bovis and E. zuernii in experimentally infected calves. Vet Rec. 1978;102(15):327-328.

[6] Levine ND. Veterinary Protozoology. Iowa State University Press; 1985.

[7] Soulsby EJL. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th ed. Bailliere Tindall; 1982.

[8] Gasser RB, Zhu XQ, McManus DP. Molecular characterization of Eimeria species from cattle by PCR-RFLP of the ITS-1 region. Int J Parasitol. 1999;29(7):1075-1080.

[9] Kvicerova J, Pakandl M, Hypsa V. Phylogenetic relationships among Eimeria spp. from cattle based on ITS-1 sequences. Vet Parasitol. 2008;152(1-2):1-8.

[10] Bangoura B, Bardsley KD, West AB, et al. A quantitative PCR assay for detection and quantification of Eimeria bovis and Eimeria zuernii in fecal samples. Vet Parasitol. 2011;176(2-3):129-135.

[11] Vereecke N, Van den Broeck W, Geldhof P, et al. Development and validation of a multiplex qPCR for the detection of pathogenic Eimeria species in cattle. Parasit Vectors. 2018;11(1):1-10.

[12] Kvicerova J, Hypsa V, Pakandl M. Multiplex PCR for the identification of Eimeria species in cattle. Vet Parasitol. 2007;148(3-4):251-257.

[13] Stockdale PHG, Niilo L. Pathogenesis of Eimeria zuernii infection in calves. Can Vet J. 1976;17(2):45-50.

[14] Gregory MW, Catchpole J, Norton CC. The pathogenesis of Eimeria bovis in calves. Res Vet Sci. 1980;28(1):1-7.

[15] Daugschies A, Najdrowski M. Eimeriosis in cattle: current understanding. J Vet Med B Infect Dis Vet Public Health. 2005;52(10):417-427.

[16] Mundt HC, Bangoura B, Rinke M, et al. Secondary bacterial infections in calves with coccidiosis. Vet Parasitol. 2005;130(1-2):51-58.

[17] Fitzgerald PR. The economic impact of coccidiosis in domestic animals. Adv Vet Sci Comp Med. 1980;24:121-143.

[18] Radostits OM, Gay CC, Hinchcliff KW, et al. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 10th ed. Saunders Elsevier; 2007.

[19] Bangoura B, Daugschies A. Parasitological and clinical parameters of experimental Eimeria zuernii infection in calves. Vet Parasitol. 2007;147(1-2):116-123.

[20] Fox JE, Kennedy TJ, Roussel AJ, et al. Subclinical coccidiosis in calves: effects on growth and feed efficiency. J Am Vet Med Assoc. 1995;206(10):1555-1559.

[21] Meyer C, Daugschies A, Bangoura B. Economic impact of subclinical coccidiosis in dairy calves. Prev Vet Med. 2017;144:1-8.

[22] USDA. Coccidiosis in U.S. Cattle: Prevalence and Economic Impact. USDA APHIS; 2012.

[23] Haberkorn A, Stoltefuss J. Studies on the mode of action of toltrazuril. Zentralbl Bakteriol Mikrobiol Hyg A. 1987;264(3-4):303-310.

[24] Mundt HC, Daugschies A, Ueberschar S, et al. Efficacy of toltrazuril against Eimeria bovis and E. zuernii in calves. Vet Rec. 2003;152(22):677-680.

[25] Wang CC. The mode of action of decoquinate. J Parasitol. 1976;62(4):565-571.

[26] Stromberg BE, Schlotthauer JC, Armstrong BD, et al. Efficacy of decoquinate for the prevention of coccidiosis in calves. Am J Vet Res. 1982;43(4):662-665.

[27] Peeters JE, Geeroms R, Vercruysse J. Comparative efficacy of anticoccidial drugs in calves. Vet Parasitol. 1988;27(3-4):213-222.

[28] Constable PD. Fluid and electrolyte therapy in diarrheic calves. Vet Clin North Am Food Anim Pract. 2003;19(3):545-561.

[29] Signorini ML, Soto JP, Zbrun MV, et al. Probiotics for the prevention of diarrhea in calves: a meta-analysis. Livest Sci. 2012;148(1-2):1-10.

[30] Chapman HD. Anticoccidial drug resistance in Eimeria species of poultry. Vet Parasitol. 1997;68(1-2):1-18.

[31] Daugschies A, Bangoura B, Lendner M. Anticoccidial resistance in cattle: a field study. Vet Parasitol. 2013;196(1-2):1-7.

[32] Rose ME, Hesketh P. Immunity to coccidiosis: stages of the life cycle and the role of T lymphocytes. Res Vet Sci. 1984;36(1):1-6.

[33] Lillehoj HS, Trout JM. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clin Microbiol Rev. 1996;9(3):349-360.

[34] Hermosilla C, Taubert A, Zahner H. Eimeria bovis: modulation of host cell functions by sporozoites. Vet Res. 2002;33(5):489-504.

[35] Shirley MW, Smith AL, Tomley FM. The biology of avian Eimeria with an emphasis on their control by vaccination. Adv Parasitol. 2005;60:285-330.

[36] Bangoura B, Daugschies A. Influence of low-level infection on the development of immunity to Eimeria bovis in calves. Vet Parasitol. 2008;153(1-2):1-7.

[37] Henriksen SA, Aagaard K. A simple flotation and McMaster method for the quantitative determination of coccidial oocysts in faeces. Nord Vet Med. 1976;28(7-8):392-397.

[38] Kvicerova J, Pakandl M, Hypsa V. Real-time PCR for detection and quantification of Eimeria species in cattle. Vet Parasitol. 2009;163(1-2):1-6.

[39] Vereecke N, Van den Broeck W, Geldhof P, et al. Multiplex qPCR for herd-level screening of bovine Eimeria species. Parasit Vectors. 2019;12(1):1-9.

[40] Faber JE, Kollmann D, Heise A, et al. Development of an ELISA for detection of antibodies against Eimeria bovis in cattle. Vet Parasitol. 2001;101(1):1-10.

[41] Daugschies A, Bangoura B, Lendner M. Management strategies for the control of coccidiosis in calves. Vet Clin North Am Food Anim Pract. 2014;30(1):1-15.

[42] Stromberg BE, Schlotthauer JC, Armstrong BD, et al. Prophylactic use of decoquinate in calves. Am J Vet Res. 1983;44(6):1045-1048.

[43] Jenkins MC, O'Brien CN, Trout JM, et al. Disinfection of Eimeria oocysts with ammonia. J Parasitol. 2002;88(5):1023-1025.

[44] Marquardt WC, Senger CM, Seghetti L. Survival of Eimeria oocysts on pasture. J Parasitol. 1960;46(4):453-458.

[45] Ernst JV, Benz GW. Eimeria species of cattle: a review. Vet Parasitol. 1986;19(3-4):181-201.

[46] Faber JE, Kollmann D, Heise A, et al. Eimeria infections in cattle: a review. Vet Med (Praha). 2002;47(6):159-172.

[47] Hammond DM, Davis LR, Bowman GW. The endogenous phase of Eimeria bovis in calves. J Protozool. 1944;1(1):1-8.

[48] Marquardt WC. The life cycle of Eimeria zuernii in calves. J Parasitol. 1959;45(3):295-302.

[49] Joyner LP, Norton CC. The prepatent period of Eimeria bovis and E. zuernii in experimentally infected calves. Vet Rec. 1978;102(15):327-328.

[50] Levine ND. Veterinary Protozoology. Iowa State University Press; 1985.